Develops oral small molecule therapies for CNS diseases by targeting demyelination and neuroinflammation with precision neurology.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Myrobalan Therapeutics develops first-in-class and best-in-class oral small molecule therapies targeting demyelination and neuroinflammation in central nervous system (CNS) diseases such as multiple sclerosis, Alzheimer’s disease, ALS, and Parkinson’s disease. The company leverages drug discovery expertise and biomarker-guided precision neurology to deliver innovative, brain-penetrant treatments for patients with CNS disorders.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Investors
3E Bioventures Capital
AB Magnitude Ventures Group
Co-Win Ventures
Guan Zi Equity Investment
Myrobalan Therapeutics Valuations & Financials
View real-time NPM data on Myrobalan Therapeutics stock including daily Myrobalan Therapeutics stock price estimates, valuation history, and historical share price information. Access Myrobalan Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Myrobalan Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Myrobalan Therapeutics? Get in touch to learn more.
Similar Companies
like Myrobalan Therapeutics
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Mercy BioAnalytics
Healthcare & Life Sciences
Develops liquid biopsy platform using extracellular vesicles for early cancer detection through blood-based diagnostic tests.
WorldViz
Builds immersive simulation tools which enable research, training, and interactive visualization across industries.
DexCare
Healthcare & Life Sciences
Healthcare technology platform that streamlines patient access and care delivery through AI-powered solutions and data integration.
Ordermark
Delivers a centralized order aggregation dashboard to integrate multi-channel digital delivery requests into a unified kitchen fulfillment workflow.
Go Green Agriculture
Climate & Sustainability
Produces fresh, local greens using advanced agricultural technology to enhance food safety and sustainability.
Electra Therapeutics
Healthcare & Life Sciences
Biotech company developing antibody therapies targeting immune system dysfunction and cancer through signal regulatory protein technology.
BeZero Carbon
Provides independent carbon credit ratings and market analytics to help organizations evaluate and invest in environmental sustainability projects.
FAQ
We have answers
Myrobalan Therapeutics stock does not trade on public stock exchanges. Myrobalan Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Myrobalan Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Myrobalan Therapeutics Stock does not trade on public stock exchanges. In order to sell Myrobalan Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Myrobalan Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Myrobalan Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Myrobalan Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Myrobalan Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Myrobalan Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Myrobalan Therapeutics is a private company and has not had an IPO. There is currently no Myrobalan Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Myrobalan Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
